Literature DB >> 24397839

JSH Guidelines for the Management of Hepatitis B Virus Infection.

.   

Abstract

Entities:  

Year:  2014        PMID： 24397839     DOI： 10.1111/hepr.12269

Source DB:  PubMed          Journal:  Hepatol Res        ISSN： 1386-6346            Impact factor:   4.288


× No keyword cloud information.
  50 in total

1.  Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.

Authors:  Arpan Patel; Suna Yapali; Anna S F Lok
Journal:  Hepatol Int       Date:  2015-08-14       Impact factor: 6.047

2.  Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.

Authors:  Akihiro Matsumoto; Shuhei Nishiguchi; Hirayuki Enomoto; Jong-Hon Kang; Yasuhito Tanaka; Noboru Shinkai; Masayuki Kurosaki; Masaru Enomoto; Tatsuo Kanda; Osamu Yokosuka; Hiroshi Yatsuhashi; Shinya Nagaoka; Chiaki Okuse; Tatehiro Kagawa; Tetsuya Mine; Koichi Takaguchi; Satoru Saito; Keisuke Hino; Fusao Ikeda; Shotaro Sakisaka; Daisuke Morihara; Shiho Miyase; Masataka Tsuge; Kazuaki Chayama; Naoki Hiramatsu; Yoshiyuki Suzuki; Kazumoto Murata; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2017-06-20       Impact factor: 7.527

3.  Reimbursement policies in the Asia-Pacific for chronic hepatitis B.

Authors:  Seng Gee Lim; Deepak N Amarapurkar; Henry Lik-Yuen Chan; Darrell H Crawford; Edward J Gane; Kwang-Hyub Han; Sang Hoon Ahn; Wasim Jafri; Jidong Jia; Jia-Horng Kao; Laurentius A Lesmana; C Rinaldi A Lesmana; Rosmawati Mohamed; Pham Hoang Phiet; Teerha Piratvisuth; Shiv K Sarin; Jose D Sollarno; Yuichiro Eguchi; Mamun-Al Mahtab; Keat Hong Lee
Journal:  Hepatol Int       Date:  2014-12-11       Impact factor: 6.047

Review 4.  Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen-Negative Patients: An Asian Perspective.

Authors:  Tung-Hung Su; Jia-Horng Kao
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

5.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

6.  Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.

Authors:  Matsuo Deguchi; Masanori Kagita; Nori Yoshioka; Hiroko Tsukamoto; Miyuki Takao; Kazuko Tahara; Ikuhiro Maeda; Yoh Hidaka; Satoshi Yamauchi; Atsushi Kaneko; Hideo Miyakoshi; Mitsuo Isomura
Journal:  J Clin Lab Anal       Date:  2017-10-06       Impact factor: 2.352

7.  Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA.

Authors:  Atsushi Tanaka; Junko Hirohara; Yasuni Nakanuma; Hirohito Tsubouchi; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2014-09-20       Impact factor: 7.527

Review 8.  Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.

Authors:  Shunsuke Mori; Shigetoshi Fujiyama
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

9.  Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.

Authors:  Akihiro Matsumoto; Masayasu Imaizumi; Yasuhito Tanaka; Shuhei Nishiguchi; Hiroshi Yatsuhashi; Takehiko Ishida; Kazushige Moriyama; Katsumi Aoyagi; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2016-07-26       Impact factor: 7.527

10.  Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.

Authors:  Masafumi Ikeda; Hiroki Yamamoto; Makiko Kaneko; Hiroshi Oshima; Hideaki Takahashi; Kumiko Umemoto; Kazuo Watanabe; Yusuke Hashimoto; Izumi Ohno; Shuichi Mitsunaga; Takuji Okusaka
Journal:  Int J Clin Oncol       Date:  2016-06-03       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.